NDRA (ENDRA Life Sciences) Prakiraan volume dodolan

Tandha merek ENDRA Life Sciences Inc (NDRA)

Regulatory barriers for software and sensors create volatility, and consequently, the valuation of future sales volume exhibits fluctuations, with the value holding at 0.00. ENDRA Life Sciences (NDRA) generates revenue based on the sale of TAEUS systems for accessible liver fat analysis. Meanwhile, business development relies on insurance reimbursement codes, remaining independent of macroeconomic cycles.

Prakiraan pendapatan perusahaan: ENDRA Corp (NDRA) kanggo 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar ENDRA (NDRA)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:ENDRA Life Sciences Inc. NDRA
Produk mawa merek ENDRA Life Sciences Inc

A defensive portfolio requires strict fundamental screening to minimize risks. This indicator quantitatively assesses expected cash flow by measuring the probability of maintaining current commercial momentum. For ENDRA Life Sciences (NDRA), this is critical due to supply chain vulnerabilities and regulatory barriers within the biopharmaceutical sector. Analyzing the company's future sales volume on GURU.Markets allows for the identification of potential momentum growth or the risk of a correction. The trend in the company's future sales volume determines the business's resilience to external shocks.